AtheroGenics diabetes drug trial meets main goal – Reuters

« « Eat This, Not That! It's the Best of Food, It's the Worst of Food  |  USF receives $128 million award for diabetes research – Bizjournals.com » »

AtheroGenics diabetes drug trial meets main goal – Reuters

Friday, August 1st, 2008    Subscribe To Our Feed

AtheroGenics diabetes drug trial meets main goal
Reuters - 13 hours ago
O: Quote, Profile, Research) said both doses of its experimental drug, AGI-1067, met the main goal in a late-stage trial to treat type 2 diabetes to reduce
AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical MarketWatch
all 13 news articles

Source:AtheroGenics diabetes drug trial meets main goal – Reuters

Share and Enjoy:
  • Digg
  • Furl
  • del.icio.us
  • Slashdot
  • Smarking
  • NewsVine
  • SphereIt
  • blinkbits
  • Reddit
  • Blue Dot
  • StumbleUpon
  • BlinkList
  • Spurl
  • Netscape

Leave a Reply

Comment moderation is enabled. Your comment may take some time to appear.